Although, the off-target cardiac effects of FGF23 are mainly attributable by a compensatory increase in FGF23 levels secondary to a state of Klotho deficiency in progressive CKD, some evidence suggests that Klotho deficiency itself also adversely affects the heart. This evidence concerns the gene FGF23 and chronic kidney disease.